Related Experiment Video
Updated: May 8, 2026

Investigating von Willebrand Factor Pathophysiology Using a Flow Chamber Model of von Willebrand Factor-platelet String Formation
Published on: August 14, 2017
The interaction between factor H and VWF increases factor H cofactor activity and regulates VWF prothrombotic status
Julie Rayes1, Lubka T Roumenina, Jordan D Dimitrov
1Institut National de la Santé et de la Recherche Médicale.
Endothelial cells (ECs) secrete von Willebrand factor (VWF) and factor H (FH), linking hemostasis and complement. Their interaction enhances complement regulation and platelet aggregation for wound healing.
Area of Science:
- Biochemistry
- Cell Biology
- Immunology
Background:
- Vascular endothelial cells (ECs) play a crucial role in hemostasis, thrombosis, and complement regulation.
- ECs synthesize both von Willebrand factor (VWF), a key clotting initiator, and factor H (FH), a complement regulator.
- The intracellular localization and interaction of VWF and FH within ECs were not well-defined.
Purpose of the Study:
- To investigate the intracellular localization and interaction of factor H (FH) and von Willebrand factor (VWF) within endothelial cells (ECs).
- To elucidate the functional consequences of the VWF-FH interaction on complement activation and hemostasis.
- To describe a novel link between the complement and hemostasis systems mediated by ECs.
Main Methods:
- Immunofluorescence microscopy to determine the colocalization of FH and VWF in human umbilical vein ECs.
- Biochemical assays to assess the binding affinity between VWF and FH.
- Functional assays to evaluate the impact of the VWF-FH complex on complement regulation (FH cofactor activity) and VWF proteolysis (ADAMTS13 activity).
- Assessment of platelet aggregation in response to the VWF-FH interaction.
Main Results:
- Factor H (FH) was found to colocalize with von Willebrand factor (VWF) in Weibel-Palade bodies (WPBs) of endothelial cells.
- FH demonstrated high-affinity binding to VWF, forming a complex detectable in normal plasma.
- The VWF-FH interaction enhanced FH's cofactor activity for complement downregulation.
- This interaction also inhibited ADAMTS13-mediated VWF cleavage and promoted platelet aggregation.
Conclusions:
- A novel interaction between the complement and hemostasis systems has been identified, involving the colocalization and binding of FH and VWF within ECs.
- The simultaneous secretion of VWF and FH by activated ECs can promote platelet adhesion at sites of endothelial injury, aiding wound healing.
- This interaction simultaneously modulates complement activation, potentially limiting bystander tissue damage during inflammatory responses.
Related Concept Videos
Extrinsic and Intrinsic Pathways of Hemostasis
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which forms a...
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Clot Retraction and Fibrinolysis
Factors Affecting Protein-Drug Binding: Drug Interactions
Displacement interactions can have varying outcomes, ranging from toxicity to virtually...
Regulation of Angiogenesis and Blood Supply

